NHS Blood and Transplant is organizing a stem cell treatment protocol in Liverpool, England for patients with diabetes related kidney disease. The randomized controlled trial will compare injections of mesenchymal stem cells with placebo injections and study whether stem cells will slow down or halt tissue damage, removing the current reliance on dialysis or transplants.
StemSave Blog
0 Comments Click here to read/write comments
Topics: kidney disease, stemsaveblog, Diabetes, clinical trial, mesenchymal stem cells, regenerative medicine